Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justyna Czapla

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
European Journal of Pharmacology|July 15, 2020
Adipose tissue-derived stromal cells stimulated macrophages-endothelial cells interactions promote effective ischemic muscle neovascularizationJustyna Czapla, Tomasz Cichoń, Ewelina Pilny, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2024
Combination of STING agonist with anti-vascular RGD-(KLAKLAK)<sub>2</sub> peptide as a novel anti-tumor therapyJustyna Czapla, Alina Drzyzga, Joanna Ciepła, et al.
Frontiers in Oncology|September 1, 2023
Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment contextJustyna Czapla, Alina Drzyzga, Sybilla Matuszczak, et al.
Cancers|January 25, 2025
Differential Response to Local Stimulator of Interferon Genes Agonist Administration in Tumors with Various Stimulator of Interferon Genes StatusesAlina Drzyzga, Justyna Czapla, Sybilla Matuszczak, et al.
Cancers|August 27, 2021
The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent-DMXAA Is Essential to Inhibit the Growth of Melanoma TumorsAlina Drzyzga, Tomasz Cichoń, Justyna Czapla, et al.
Cells|February 11, 2023
Novel Local "Off-the-Shelf" Immunotherapy for the Treatment of Myeloma Bone DiseaseSandra Charvátová, Benjamin Motais, Justyna Czapla, et al.
International Journal of Molecular Sciences|July 2, 2020
Brachytherapy in a Single Dose of 10Gy as an "in situ" VaccinationMagdalena Jarosz-Biej, Ryszard Smolarczyk, Tomasz Cichoń, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2025
Correction: Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonistMagdalena Jarosz-Biej, Justyna Czapla, Joanna Ciepła, et al.
Scientific Reports|September 16, 2021
Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanomaNatalia Kułach, Ewelina Pilny, Tomasz Cichoń, et al.
Plos One|January 11, 2018
M1-like macrophages change tumor blood vessels and microenvironment in murine melanomaMagdalena Jarosz-Biej, Natalia Kamińska, Sybilla Matuszczak, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|July 15, 2020
Adipose tissue-derived stromal cells stimulated macrophages-endothelial cells interactions promote effective ischemic muscle neovascularizationJustyna Czapla, Tomasz Cichoń, Ewelina Pilny, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2024
Combination of STING agonist with anti-vascular RGD-(KLAKLAK)<sub>2</sub> peptide as a novel anti-tumor therapyJustyna Czapla, Alina Drzyzga, Joanna Ciepła, et al.
Frontiers in Oncology|September 1, 2023
Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment contextJustyna Czapla, Alina Drzyzga, Sybilla Matuszczak, et al.
Cancers|January 25, 2025
Differential Response to Local Stimulator of Interferon Genes Agonist Administration in Tumors with Various Stimulator of Interferon Genes StatusesAlina Drzyzga, Justyna Czapla, Sybilla Matuszczak, et al.
Cancers|August 27, 2021
The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent-DMXAA Is Essential to Inhibit the Growth of Melanoma TumorsAlina Drzyzga, Tomasz Cichoń, Justyna Czapla, et al.
Cells|February 11, 2023
Novel Local "Off-the-Shelf" Immunotherapy for the Treatment of Myeloma Bone DiseaseSandra Charvátová, Benjamin Motais, Justyna Czapla, et al.
International Journal of Molecular Sciences|July 2, 2020
Brachytherapy in a Single Dose of 10Gy as an "in situ" VaccinationMagdalena Jarosz-Biej, Ryszard Smolarczyk, Tomasz Cichoń, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2025
Correction: Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonistMagdalena Jarosz-Biej, Justyna Czapla, Joanna Ciepła, et al.
Scientific Reports|September 16, 2021
Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanomaNatalia Kułach, Ewelina Pilny, Tomasz Cichoń, et al.
Plos One|January 11, 2018
M1-like macrophages change tumor blood vessels and microenvironment in murine melanomaMagdalena Jarosz-Biej, Natalia Kamińska, Sybilla Matuszczak, et al.
Pageof 3